Abstract
The PML gene of acute promyelocytic leukaemia (APL) encodes a cell growth and tumour suppressor, however, the mechanisms by which PML suppresses tumorigenesis are poorly understood. We show here that Pml is required for Fas- and caspase-dependent DNA-damage–induced apoptosis. We also found that Pml is essential for induction of programmed cell death by Fas, tumour necrosis factor α (TNF), ceramide and type I and II interferons (IFNs). As a result, Pml –/– mice and cells are protected from the lethal effects of ionizing radiation and anti-Fas antibody. Pml is required for caspase 1 and caspase 3 activation upon exposure to these stimuli. The PML-RARα fusion protein of APL renders haemopoietic progenitor cells resistant to Fas-, TNF- and IFN-induced apoptosis with a lack of caspase 3 activation, thus acting as a Pml dominant-negative product. These results demonstrate that Pml is a mediator of multiple apoptotic signals, and implicate inhibition of apoptosis in the pathogenesis of APL.
Similar content being viewed by others
References
Pandolfi, P.P. et al. Structure and origin of the acute promyelocytic leukaemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6, 1285– 1292 (1991).
de The, H. et al. The PML/RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukaemia encodes a functionally altered RAR. Cell 66, 675–684 (1991).
Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukaemia fuses RARα with a novel putative transcription factor, PML. Cell 66, 663–674 (1991).
Goddard, A.D., Borrow, J., Freemont, I. & Solomon, E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371–1374 (1991).
Kalantry, S. et al. Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia. J. Cell. Phys. 173, 288–296 (1997).
Kastner, P. et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11, 629–642 (1992).
Perez, A. et al. PML/RAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J. 12, 3171– 3182 (1993).
Freemont, P.S., Hanson, I.M. & Trowsdale, J. A novel cysteine-rich sequence motif. Cell 64, 483–484 (1991).
Borden, K.L. & Freemont, P.S. The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6, 395–401(1996).
Borden, K.L. et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 14, 1532–1541 (1995).
Lamond, A.I. & Earnshaw, W.C. Structure and function in the nucleus. Science 280, 547– 553 (1998).
Hodges, M., Tissot, C., Howe, K., Grimwade, D. & Freemont, P.S. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63, 297–304 (1998).
Stadler, M. et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and GAS element. Oncogene 11, 2565–2573 (1995).
Lavau, C. et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871–876 (1995).
Nason-Burchenal, K. et al. Interferon augments PML and PML/RARα expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid resistant promyelocytic cell line. Blood 88, 3926–3936 (1996).
Wang, Z.G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547–1551 (1998).
Koken, M.H.M. et al. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073–1083 (1994).
Dyck, J. et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333– 343 (1994).
Weis, K. et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemic cells. Cell 76, 345–356 (1994).
Grignani, F. et al. The acute promyelocytic leukaemia specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423–431 (1993).
Strasser, A., Harris, A.W., Jacks, T. & Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329– 339 (1994).
Reap, E.A. et al. Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc. Natl Acad. Sci. USA 94, 5750–5755 (1997).
Nagata, S. Apoptosis by death factors. Cell 88, 355–365 (1997).
Enari, M., Hug, H. & Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78–81 (1995).
Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993).
Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317 (1992).
Enari, M., Talanian, R.V., Wong, W.W. & Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380, 723– 726 (1996).
Tamura T. et al. An IRF-1 dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376, 596–599 (1995).
Kolesnick, R.N. & Krönke, M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643–665 (1998).
Smyth, M.J. et al. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem. J. 316, 25–28 (1996).
Chinnaiyan A.M. et al. FADD/MORT1 is a common mediator of CD95 (Fas/Apo-1) and tumor necrosis factor receptor induced apoptosis. J. Biol. Chem. 271, 4961–4965 (1996).
Selleri, C. et al. Interferon-γ and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death. J. Cell. Phys. 165, 538– 546 (1995).
Maciejewski, J. et al. Fas antigen expression on CD34+ human marrow cells is induced by interferon-γ and tumor necrosis factor-α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85, 3183–3190 (1995).
He, L.Z. et al. Acute leukemia with promyelocytic features in PML-RARα transgenic mice. Proc. Natl Acad. Sci. USA 94, 5302–5307 (1997).
He, L.Z. et al. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nature Genet. 18, 126–135 (1998).
Quignon, F. et al. PML induces a caspase-independent death associated with BAX recruitment to nuclear bodies. Nature Genet. 20, 259–265 (1998).
Penninger, J.M. & Kroemer, G. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv. Immunol. 68, 51–144 (1998).
Lenardo, M.J. The molecular regulation of lymphocyte apoptosis. Semin. Immunol. 9, 1–5 (1997).
Hong, S.H. et al. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc. Natl Acad. Sci. USA 94, 9038–9033 (1997).
Grignani, F. et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature 391, 815–818 (1998).
Lin, R.J. et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391, 811– 814 (1998).
Acknowledgements
We thank M. Barna, M. Giorgio, E. Rego, K. Elkon, C. Cordon-Cardo, R. Dalla Favera, H.T. Petrie, S. Landolfo, P. Freemont, L. Longo and L. Luzzatto for materials, advice and help. Partially supported by the 'American Italian Cancer Foundation' (D.R.), the 'Associazione Italiana per la Ricerca sul Cancro' (M.G., R.R.) and 'Centro Nazionale per la Ricerca' (S.R.). P.P.P. is a Scholar of the Leukemia Society of America. Supported by the Sloan-Kettering Institute (CA-08748) and NIH (CA 71692 awarded to P.P.P.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, ZG., Ruggero, D., Ronchetti, S. et al. Pml is essential for multiple apoptotic pathways. Nat Genet 20, 266–272 (1998). https://doi.org/10.1038/3073
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/3073
- Springer Nature America, Inc.
This article is cited by
-
PML-II regulates ERK and AKT signal activation and IFNα-induced cell death
Cell Communication and Signaling (2021)
-
Identification of novel interaction between Promyelocytic Leukemia protein and human Alteration/Deficiency in Activation 3 coactivator and its role in DNA damage response
Journal of Proteins and Proteomics (2019)
-
PML: Regulation and multifaceted function beyond tumor suppression
Cell & Bioscience (2018)
-
Functions and dys-functions of promyelocytic leukemia protein PML
Rendiconti Lincei. Scienze Fisiche e Naturali (2018)
-
Uncovering the SUMOylation and ubiquitylation crosstalk in human cells using sequential peptide immunopurification
Nature Communications (2017)